The largest hospital for infectious diseases and COVID-19 patients, the modular Leishenshan Hospital was created with "China Speed," surprising the world with its 14-day construction.
CSADI and Dassault Systèmes are using the 3DEXPERIENCE platform's simulation capabilities to simulate virus contamination and diffusion within the hospital's ventilation system and to counteract the negative effects from unplanned ventilation risks.
As a strategic partner of Dassault Systèmes in China, CSADI undertook the design of Leishenshan Hospital. Avoiding contamination of nearby environments is a key consideration for CSADI, especially the minimisation of cross-infection in the hospital and any impacts on external communities, crowds and surroundings.
To this end, Dassault Systèmes has donated SIMULIA XFlow software, powered by the 3DEXPERIENCE platform, to CSADI to simulate indoor and outdoor fluids, virus dispersal in ventilation systems, as well as other projects within Leishenshan Hospital.
Dassault Systèmes provide business and people with collaborative 3D virtual environments to imagine sustainable innovations.
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities
60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study
Hologic receives FDA clearance and CE mark for new gastrointestinal bacterial assays
LakeShore Biopharma receives Nasdaq delisting determination letter
CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio
Bavarian Nordic chikungunya vaccine enters Health Canada review process
Ondine Biomedical completes world-first ICU study with Steriwave nasal therapy
Centivax raises USD45m to commercialise universal flu vaccine
SCG Cell's SCG101V therapy Investigational New Drug Application receives Chinese regulatory approval